Himalaya Nutravedics

Himalaya Nutravedics SME IPO

Listed

BSE SMEOpens 22 September 2026Closes 24 September 2026

Himalaya Nutravedics India Ltd is engaged in the manufacturing, marketing, and distribution of Ayurvedic and nutraceutical formulations in India. In addition to its own branded products, the company also undertakes…

Show more
Live GMPSubscriptionAllotment
Price band
₹100 - ₹106
Issue size
₹26.50 Cr
Lot size
1,200 shares
Type
BSE SME
GMP
₹0 (0.0%)
Est. listing
₹106
Est. profit / app
—
Retail quota
35.00%

Key ratios

As per RHP / filings
Face value
₹10
EPS
8.39
P/E ratio
12.63
RoNW
45.12%
ROE
63.87%
Debt / Equity
0.31
Advertisement

Timeline

  1. IPO Opens

    22 Sept 2026

  2. IPO Closes

    24 Sept 2026

  3. Allotment

    25 Sept 2026

  4. Listing

    29 Sept 2026

IPO Timeline & Listing Details

EventDate
IPO Open Date22 September 2026
IPO Close Date24 September 2026
Allotment Date25 September 2026
Listing Date29 September 2026

Investment Categories

CategoryLotsAmount
Individual
2₹2,54,400
SHNI (Min)
3₹3,81,600
SHNI (Max)
7₹8,90,400
BHNIAbove ₹10,00,000
8₹10,17,600

IPO Reservation Details

CategoryReservation
QIB (Qualified Institutional Buyer)50.00%
NII (Non-Institutional Investor)15.00%
SHNI (Small Non-Institutional Investor)5.00%
BHNI (Big Non-Institutional Investor)10.00%
Retail35.00%
Total100.00%

IPO Objectives

  • Funding Working Capital Requirements (₹13.75 Cr).
  • Business Development and Digital Marketing Activities (₹7.50 Cr).
  • General Corporate Purposes.

Strengths

  • Integrated multi-dosage manufacturing capabilities encompassing soft gels, tablets, and liquids.
  • Balanced hybrid business model featuring both own-brand formulations and third-party contract manufacturing.
  • Doctor acceptance supported by product performance rather than mass advertising.
  • Broad therapeutic coverage spanning from digestive health to musculoskeletal and joint care.

Weaknesses

  • Negative operating cash flows indicating working-capital movements exceeding operating profit.
  • Geographic concentration of revenue primarily across southern states and specific parts of north India like Uttar Pradesh and Gujarat.
  • Susceptibility to stringent compliance mechanisms and quality restrictions within the domestic nutraceutical and pharmaceutical spheres.
Advertisement

Financial Performance

Period Ended31 Mar 202631 Mar 202531 Mar 2024
Assets (₹ Cr.)24.4210.826.09
Revenue (₹ Cr.)43.122114.43
PAT (₹ Cr.)7.392.230.43
Net Worth (₹ Cr.)16.386.751.34

Peer Comparison

CompanyP/B RatioP/E RatioRONW (%)Net Worth (₹ Cr.)
Himalaya Nutravedics3.9712.6345.12%16.38

Subscription Details

Daily Bids Status

CategoryDay 1Day 2Day 3
QIB0x0x1x
NII0.14x0.32x3.58x
S-HNI0.21x0.54x3.04x
B-HNI0.1x0.47x3.84x
RII0.16x0.67x2.56x
Total0.11x0.4x2.33x

Overall Subscription Statistics

CategoryShares OfferedShares BidBid Amount (₹ Cr)
QIB4,74,0004,74,0005.02
NII3,56,40012,74,40013.51
Small NII1,18,8003,61,2003.83
Big NII2,37,6009,13,2009.68
RII8,32,80021,33,60022.62
Total16,63,20038,82,00041.15
Advertisement

Company Details

  • Himalaya Nutravedics India Ltd.
  • Plot No. 101/A, Phase-III, Industrial Development Park, Cherlapally, Hindustan Cables Ltd, Uppal, Hyderabad, Telangana – 500051
  • +91-9063498493
  • info@himalayanutravedics.com
  • https://www.himalayanutravedics.com/

Registrar Details

Frequently Asked Questions

What is the core business of Himalaya Nutravedics India Ltd.?
Himalaya Nutravedics India Ltd is engaged in the manufacturing, marketing, and distribution of Ayurvedic formulations and nutraceutical supplements, serving both direct-to-market brands and providing contract manufacturing services.
When does the Himalaya Nutravedics SME IPO open and close?
The IPO opens for bidding on Tuesday, September 22, 2026, and closes on Thursday, September 24, 2026.
What is the price band and minimum retail application size for the IPO?
The price band is fixed at ₹100.00 to ₹106.00 per equity share. Retail investors can apply for a minimum of 2 lots, comprising 2,400 shares, which requires an investment of ₹2,54,400 at the upper price band of ₹106.
What is the total issue size and structure of the Himalaya Nutravedics IPO?
The total issue size is ₹26.50 Crore, which consists entirely of a Fresh Issue of 24,99,600 equity shares with no Offer for Sale (OFS) component.
When and where will the shares of Himalaya Nutravedics list?
The equity shares are scheduled to list on the BSE SME platform on Tuesday, September 29, 2026.

Himalaya Nutravedics SME IPO News & Updates

Follow the latest updates for Himalaya Nutravedics SME IPO, including grey market moves and allotment news.

Himalaya Nutravedics SME IPO IPO Pages

Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.

Himalaya Nutravedics SME IPO Details

Issue size, price, financials, and company info

Himalaya Nutravedics SME IPO GMP

Live grey market premium and listing estimate

Himalaya Nutravedics SME IPO Subscription

QIB, NII, Retail, SHNI and BHNI subscription

Himalaya Nutravedics SME IPO Allotment

Allotment date, chances, and check by PAN

Himalaya Nutravedics SME IPO Review

SWOT, strengths, risks, and IPO review

Himalaya Nutravedics SME IPO FAQ

Common questions on dates, GMP, and allotment

Himalaya Nutravedics SME IPO Registrar

Registrar website and how to check allotment

Himalaya Nutravedics SME IPO Timeline

Open, close, allotment, and listing dates

Himalaya Nutravedics SME IPO News

Updates, blogs, and latest IPO news

Sources

We match Himalaya Nutravedics SME IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.

  • SEBIRules for IPO allotment and disclosures in India
  • NSEExchange notices, bidding data, and listing updates
  • BSEExchange notices and IPO allotment check tools
  • RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
  • Kfin Technologies Ltd.Official site to check allotment status for this IPO

Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.

Reviewed by

Dinesh Agrawal · Lead IPO Analyst

15+ years in Indian markets and IPO research. He reviews IPO dates and key details before they go live.

Loading comments...